- Home
- CBNK vs ALMS Comparison
CBNK vs ALMS Comparison
Compare CBNK & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBNK
- ALMS
- Stock Information
- Founded
- CBNK 1974
- ALMS 2021
- Country
- CBNK United States
- ALMS United States
- Employees
- CBNK N/A
- ALMS N/A
- Industry
- CBNK Major Banks
- ALMS
- Sector
- CBNK Finance
- ALMS
- Exchange
- CBNK Nasdaq
- ALMS NYSE
- Market Cap
- CBNK 471.8M
- ALMS 402.6M
- IPO Year
- CBNK 2018
- ALMS 2024
- Fundamental
- Price
- CBNK $32.38
- ALMS $3.50
- Analyst Decision
- CBNK Hold
- ALMS Strong Buy
- Analyst Count
- CBNK 1
- ALMS 7
- Target Price
- CBNK $35.00
- ALMS $26.83
- AVG Volume (30 Days)
- CBNK 83.9K
- ALMS 1.1M
- Earning Date
- CBNK 07-21-2025
- ALMS 05-14-2025
- Dividend Yield
- CBNK 1.24%
- ALMS N/A
- EPS Growth
- CBNK 6.54
- ALMS N/A
- EPS
- CBNK 2.49
- ALMS N/A
- Revenue
- CBNK $188,910,000.00
- ALMS $17,389,000.00
- Revenue This Year
- CBNK $46.92
- ALMS N/A
- Revenue Next Year
- CBNK $7.82
- ALMS N/A
- P/E Ratio
- CBNK $12.96
- ALMS N/A
- Revenue Growth
- CBNK 20.92
- ALMS N/A
- 52 Week Low
- CBNK $19.45
- ALMS $3.18
- 52 Week High
- CBNK $34.31
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- CBNK 57.70
- ALMS N/A
- Support Level
- CBNK $32.21
- ALMS N/A
- Resistance Level
- CBNK $32.99
- ALMS N/A
- Average True Range (ATR)
- CBNK 0.88
- ALMS 0.00
- MACD
- CBNK -0.20
- ALMS 0.00
- Stochastic Oscillator
- CBNK 32.00
- ALMS 0.00
About CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.